News & Updates
Filter by Specialty:
Testosterone therapy in women may lower risks of MACE, breast cancer
Women on testosterone therapy (TTh) show a lower risk of major adverse cardiac events (MACE) than matched controls, while postmenopausal women have a comparable MACE risk and a similar or significantly reduced risk of breast cancer on age-based subanalysis, reports a study.
Testosterone therapy in women may lower risks of MACE, breast cancer
04 Jun 2024
Low-dose aspirin for AMD prevention? ASPREE data show no benefit
Use of aspirin at 100 mg per day proved unsuccessful at reducing the incidence of age-related macular degeneration (AMD) in a large cohort of older healthy individuals, according to medium-term data from the AMD substudy of the Aspirin in Reducing Events in the Elderly (ASPREE) trial.
Low-dose aspirin for AMD prevention? ASPREE data show no benefit
01 Jun 2024
Arginine depletion plus chemo ups survival in rare lung cancer
In the pivotal phase II/III ATOMIC-Meso* trial, adding the first-in-class, arginine-depleting agent pegargiminase to standard first-line platinum-pemetrexed chemotherapy prolongs overall survival (OS) and progression-free survival (PFS) in patients with treatment-naïve, nonresectable, nonepithelioid pleural mesothelioma.
